{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2013"],"condition":["Opioid-induced Constipation in Subjects with Non-malignant Chronic Pain Receiving Opioid Therapy","Opioid-Induced Constipation","Opioid induced constipation","Constipation"],"disease":["Opioid Induced Constipation","Opioid-induced Constipation","Constipation","Opioid-induced Constipation In Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2153377"],"location":["Hungary","Czechia","United States","United Kingdom","Portugal","Spain","Canada","Sweden","Austria","Belgium","Denmark","Poland","Italy","South Africa","Israel","France","Australia","Germany","Estonia"],"study_start_month":["9"],"keyword":["Naldemedine","Opioid Induced Constipation"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Long Term Safety of Naldemedine","description":"The purpose of this study is to evaluate the long-term safety of naldemedine for the treatment of constipation due to opioid therapy.","dates":{"creation":"2013-09-15"},"accession":"2153377","cross_references":{"ClinicalTrials___gov":["NCT01965652"],"EU Clinical Trials Register":["2013-002949-11"]}}